Guidance for completing the Drug Submission Application Form
For Drug Identification Number applications, a separate completed HC/SC 3011 must be provided for each formulation, strength and dosage form. For all other submission types, only a separate completed Part 2 must be provided for each formulation, strength and dosage form.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-01
Data overview
- Formats
- HTML
- File languages
- English, French